Get the Stockscreener App
7.84
4.16%
-0.34
Fennec Pharmaceuticals Inc stock is traded at $7.84, with a volume of 54,838.
It is down -4.16% in the last 24 hours and down -5.54% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$8.18
Open:
$8.13
24h Volume:
54,838
Relative Volume:
0.69
Market Cap:
$216.38M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-12.85
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
-9.15%
1M Performance:
-5.54%
6M Performance:
+20.62%
1Y Performance:
+25.04%
1-Day Range:
$7.84
$8.16
1-Week Range:
$7.84
$8.82
52-Week Range:
$3.96
$9.30
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.84 | 225.92M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
What data driven models say about Fennec Pharmaceuticals Inc.’s futureTrend Confirmation Scanner with Entry Focus - Newser
Using data filters to optimize entry into Fennec Pharmaceuticals Inc.Weekly Stock Movement Prediction Watchlist - Newser
What makes Fennec Pharmaceuticals Inc. stock price move sharplyMulti-Bagger Detection with Trend Tools - Newser
Is it the right time to buy Fennec Pharmaceuticals Inc. stockChart Pattern Planner That Work - jammulinksnews.com
What institutional investors are buying Fennec Pharmaceuticals Inc. stockChart Pattern Report Backed By Experts - jammulinksnews.com
Is it too late to sell Fennec Pharmaceuticals Inc.Secure Entry Point Finder with Analysis - Newser
Evaluating Fennec Pharmaceuticals Inc. with trendline analysisReal-Time AI Entry Forecast Generator - Newser
Published on: 2025-08-01 07:36:16 - metal.it
Using economic indicators to assess Fennec Pharmaceuticals Inc. potentialFree Entry Zone Strategy for Consistent Profit - Newser
Fennec Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsEarly Entry Ideas with Momentum Potential - Newser
How to track smart money flows in Fennec Pharmaceuticals Inc.Portfolio Allocation Strategy for Stability - Newser
How Fennec Pharmaceuticals Inc. stock performs during market volatilityDay Trading Setup Forecast with Trend Model - Newser
Published on: 2025-07-30 01:26:10 - metal.it
What is Fennec Pharmaceuticals Inc. company’s growth strategyExpert Picks Forecasts Backed By Experts - jammulinksnews.com
How does Fennec Pharmaceuticals Inc. compare to its industry peersBest Dividend Insights For Fast Growth - jammulinksnews.com
Is Fennec Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Growth Based Investment Plan Guidance Highlighted - metal.it
What is the risk reward ratio of investing in Fennec Pharmaceuticals Inc. stockAchieve superior capital gains with smart trades - jammulinksnews.com
New Product Launches: Will They Boost Fennec Pharmaceuticals Inc. Stock in 2025Weekly Market Direction and Sector Summary - Newser
Is Fennec Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025 Free Smart Trend Trading with Weekly Signals - metal.it
When is Fennec Pharmaceuticals Inc. stock expected to show significant growthInvest confidently with real-time data analysis - jammulinksnews.com
Why is Fennec Pharmaceuticals Inc. stock attracting strong analyst attentionAchieve rapid portfolio appreciation today - jammulinksnews.com
Published on: 2025-07-27 23:31:56 - jammulinksnews.com
Is Fennec Pharmaceuticals Inc. a growth stock or a value stockCapitalize on market trends with confidence - jammulinksnews.com
What drives Fennec Pharmaceuticals Inc. stock pricePhenomenal wealth increase - PrintWeekIndia
Is Fennec Pharmaceuticals Inc. a good long term investmentSignificant capital appreciation - PrintWeekIndia
What analysts say about Fennec Pharmaceuticals Inc. stockUnrivaled growth potential - jammulinksnews.com
Fennec Pharmaceuticals Inc. Stock Analysis and ForecastTriple returns potential - Autocar Professional
How To Trade (FENC) - news.stocktradersdaily.com
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fennec Pharmaceuticals Inc Stock (FENC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A | Director |
Jul 07 '25 |
Sale |
8.71 |
1,119 |
9,746 |
54,792 |
| Raykov Rosty | Director |
Jul 03 '25 |
Sale |
8.61 |
10,000 |
86,100 |
60,670 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):